Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Jun Kim

Showing results (181-190 of 425) with videos related to

Pageof 43
Sort By:
Journal of Gastroenterology and Hepatology|October 21, 2011
Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapyGoh Eun Chung, Won Kim, Jeong-Hoon Lee, et al.
Cardiovascular Diabetology|September 12, 2024
Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groupsEun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, et al.
Cancers|November 14, 2023
Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center StudyHeechul Nam, Hyun Yang, Ho Soo Chun, et al.
Journal of Korean Medical Science|November 8, 2018
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma RecurrenceSeong Hee Kang, Hyeki Cho, Eun Ju Cho, et al.
European Journal of Pharmacology|June 10, 2015
Hepatoprotective effect of vitamin C on lithocholic acid-induced cholestatic liver injury in Gulo(-/-) miceSu Jong Yu, Seyeon Bae, Jae Seung Kang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2021
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil FumarateKwan Soo Byun, Jonggi Choi, Ji-Hoon Kim, et al.
Gut and Liver|November 8, 2018
Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte RatioJeong-Ju Yoo, Eun Ju Cho, Bora Lee, et al.
Oncotarget|May 27, 2017
Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteriaYuri Cho, Jeong-Hoon Lee, Dong Hyeon Lee, et al.
Gut and Liver|July 17, 2025
Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver DiseaseYunmi Ko, Moon Haeng Hur, Youngsu Park, et al.
Oncology Reports|April 2, 2011
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growthGoh Eun Chung, Jung-Hwan Yoon, Jeong-Hoon Lee, et al.
Pageof 43

Showing results (181-190 of 425) with videos related to

Sort By:
Pageof 43
Journal of Gastroenterology and Hepatology|October 21, 2011
Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapyGoh Eun Chung, Won Kim, Jeong-Hoon Lee, et al.
Cardiovascular Diabetology|September 12, 2024
Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groupsEun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, et al.
Cancers|November 14, 2023
Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center StudyHeechul Nam, Hyun Yang, Ho Soo Chun, et al.
Journal of Korean Medical Science|November 8, 2018
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma RecurrenceSeong Hee Kang, Hyeki Cho, Eun Ju Cho, et al.
European Journal of Pharmacology|June 10, 2015
Hepatoprotective effect of vitamin C on lithocholic acid-induced cholestatic liver injury in Gulo(-/-) miceSu Jong Yu, Seyeon Bae, Jae Seung Kang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2021
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil FumarateKwan Soo Byun, Jonggi Choi, Ji-Hoon Kim, et al.
Gut and Liver|November 8, 2018
Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte RatioJeong-Ju Yoo, Eun Ju Cho, Bora Lee, et al.
Oncotarget|May 27, 2017
Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteriaYuri Cho, Jeong-Hoon Lee, Dong Hyeon Lee, et al.
Gut and Liver|July 17, 2025
Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver DiseaseYunmi Ko, Moon Haeng Hur, Youngsu Park, et al.
Oncology Reports|April 2, 2011
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growthGoh Eun Chung, Jung-Hwan Yoon, Jeong-Hoon Lee, et al.
Pageof 43